| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/12/1999 | CA2317476A1 Hydroxamic and carboxylic acid derivatives |
| 08/12/1999 | CA2316860A1 Three-dimensional structures and models of fc receptors and uses thereof |
| 08/12/1999 | CA2310041A1 Lipid mixtures and their use |
| 08/12/1999 | CA2286174A1 Benzyloxy prodigiosine compounds |
| 08/11/1999 | EP0934954A1 Branched cyclodextrin clathrate compound of hinokitiols and composition containing the same |
| 08/11/1999 | EP0934949A1 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives |
| 08/11/1999 | EP0934944A1 7-bromo- and 7,7-dibromo-cepham and cephem derivatives and their use as protease inhibitors |
| 08/11/1999 | EP0934942A1 Novel beta-lactam compounds and process for preparing the same |
| 08/11/1999 | EP0934939A1 Neuraminic acid compounds |
| 08/11/1999 | EP0934937A1 Azole derivatives as superoxide radical inhibitor |
| 08/11/1999 | EP0934934A2 Methods of preparing substituted 3-phenyl- and 3-pyridyl-4(3H)-quinazolinones and atropisomers thereof |
| 08/11/1999 | EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators |
| 08/11/1999 | EP0934928A1 Cyclic amine derivatives |
| 08/11/1999 | EP0934745A1 Use of androsterone derivatives for inhibiting DNA binding of ap-1 and airway smooth muscle proliferation |
| 08/11/1999 | EP0934744A1 Nitroglycerin preparation for treatment of erectile dysfunction |
| 08/11/1999 | EP0934742A2 High glycerin containing anti-microbial cleansers |
| 08/11/1999 | EP0934593A1 Electrically conductive adhesive hydrogels |
| 08/11/1999 | EP0934531A1 Diagnosis of spongiform encephalopathy |
| 08/11/1999 | EP0934424A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 08/11/1999 | EP0934412A1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF |
| 08/11/1999 | EP0934409A2 Diabetes-mediating proteins and therapeutic uses thereof |
| 08/11/1999 | EP0934404A1 Inhibition of proliferation of cells |
| 08/11/1999 | EP0934352A1 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption |
| 08/11/1999 | EP0934341A1 Inclusion complexes of beta-2-andrenergics for oral mucosal delivery |
| 08/11/1999 | EP0934340A1 Novel compounds |
| 08/11/1999 | EP0934336A1 Novel compounds |
| 08/11/1999 | EP0934335A1 Novel compounds |
| 08/11/1999 | EP0934334A1 8(9)-dehydroestradiol derivatives |
| 08/11/1999 | EP0934331A2 Mirror-symmetrical selection and evolution of nucleic acids |
| 08/11/1999 | EP0934326A1 Substituted aminoalkane phosphonic acids |
| 08/11/1999 | EP0934325A1 Tetraphosphonate bicyclic trisanhydrides |
| 08/11/1999 | EP0934321A1 Thienopyrimidine with phosphodiesterase v inhibiting effect |
| 08/11/1999 | EP0934320A1 Naphthyridine derivatives |
| 08/11/1999 | EP0934319A1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS |
| 08/11/1999 | EP0934318A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 08/11/1999 | EP0934317A2 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 08/11/1999 | EP0934316A1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 08/11/1999 | EP0934314A1 N-substituted azaheterocyclic compounds |
| 08/11/1999 | EP0934313A1 N-substituted azaheterocyclic compounds |
| 08/11/1999 | EP0934312A1 1,4-disubstituted piperazines |
| 08/11/1999 | EP0934311A2 New heterocyclylmethyl-substituted pyrazol derivates |
| 08/11/1999 | EP0934310A1 THIO ACID DERIVED MONOCYCLIC $i(N)-HETEROCYCLICS AS ANTICOAGULANTS |
| 08/11/1999 | EP0934309A1 New pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 08/11/1999 | EP0934308A1 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 08/11/1999 | EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 08/11/1999 | EP0934306A1 N-substituted azaheterocyclic compounds |
| 08/11/1999 | EP0934305A1 Integrin antagonists |
| 08/11/1999 | EP0934304A1 2-pyrimidineamine derivatives and processes for their preparation |
| 08/11/1999 | EP0934303A2 Compounds useful for inhibition of farnesyl protein transferase |
| 08/11/1999 | EP0934301A1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors |
| 08/11/1999 | EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 08/11/1999 | EP0934299A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/11/1999 | EP0934298A1 NOVEL (+)-ENANTIOMERS OF $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/11/1999 | EP0934297A1 NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/11/1999 | EP0934295A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 08/11/1999 | EP0934293A1 Novel compounds and compositions for treating diseases associated with tryptase activity |
| 08/11/1999 | EP0934292A1 Metalloproteinase inhibitors |
| 08/11/1999 | EP0934291A1 Protease inhibitors |
| 08/11/1999 | EP0934290A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 08/11/1999 | EP0934288A1 Oxadiazoles, processes for their preparation and their use as medicaments |
| 08/11/1999 | EP0934287A1 Heterocyclic esters and amides |
| 08/11/1999 | EP0934286A1 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 08/11/1999 | EP0934282A1 1,4-benzodiazepinones and their uses as cck antagonists |
| 08/11/1999 | EP0934281A1 1-phenyl-benzimidazole compounds and their use as baga- a? receptor modulators |
| 08/11/1999 | EP0934280A1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives |
| 08/11/1999 | EP0934278A1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents |
| 08/11/1999 | EP0934277A1 Process for the preparation of n- 2-(dimethylamino)ethyl]acridine-4-carboxamide |
| 08/11/1999 | EP0934276A1 Anthranilic acid derivatives as multi drug resistance modulators |
| 08/11/1999 | EP0934274A1 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents |
| 08/11/1999 | EP0934273A1 New derivates from piperidine-keto acid, their preparation and use |
| 08/11/1999 | EP0934271A1 Substituted arylalkylamines as neurokinin antagonists |
| 08/11/1999 | EP0934270A1 A method of treating cancer |
| 08/11/1999 | EP0934267A1 $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS |
| 08/11/1999 | EP0934265A1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| 08/11/1999 | EP0934264A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 08/11/1999 | EP0934263A1 Heterocyclic thioesters and ketones |
| 08/11/1999 | EP0934262A1 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors |
| 08/11/1999 | EP0934259A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 08/11/1999 | EP0934257A1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones |
| 08/11/1999 | EP0934249A1 Conformationally restricted polyamines and their use as antineoplastic agents |
| 08/11/1999 | EP0934080A2 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 08/11/1999 | EP0934079A1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
| 08/11/1999 | EP0934078A2 Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
| 08/11/1999 | EP0934076A1 Solid phase lipoglycopeptide library, compositions and methods |
| 08/11/1999 | EP0934075A2 Method for the prevention and treatment of mastitis |
| 08/11/1999 | EP0934074A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract |
| 08/11/1999 | EP0934071A1 Non-aqueous colonic purgative formulations |
| 08/11/1999 | EP0934069A1 Method and composition for the treatment of lipid and glucose metabolism disorders |
| 08/11/1999 | EP0934068A1 Compounds and methods |
| 08/11/1999 | EP0934067A1 Antimicrobial compositions |
| 08/11/1999 | EP0934066A1 Il-8 receptor antagonists |
| 08/11/1999 | EP0934065A1 Pharmaceutical compounds |
| 08/11/1999 | EP0934064A1 Thrombin inhibitors |
| 08/11/1999 | EP0934063A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
| 08/11/1999 | EP0934062A1 Antioxidant activity of 3-dehydroshikimates |
| 08/11/1999 | EP0934061A1 Isobutylgaba and its derivatives for the treatment of pain |
| 08/11/1999 | EP0934060A1 Dietary supplements |
| 08/11/1999 | EP0934059A1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
| 08/11/1999 | EP0934058A2 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
| 08/11/1999 | EP0934057A1 Medicinal aerosol formulations of formoterol |